Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy

被引:10
|
作者
Moreira, Rita Ilhao [1 ]
Abreu, Ana [1 ]
Portugal, Guilherme [1 ]
Oliveira, Luis [2 ]
Oliveira, Mario [1 ]
Rodrigues, Ines [1 ]
Cruz, Madalena Coutinho [1 ]
Cunha, Pedro Silva [1 ]
Santos, Vanessa [3 ]
Clara, Helena Santa [3 ]
Carmo, Miguel Mota [1 ,4 ]
Ferreira, Rui Cruz [1 ]
机构
[1] Hosp Santa Marta, Centro Hospitalar Lisboa Cent, Dept Cardiol, Rua Santa Marta, . 50, P-1169-024 Lisbon, Portugal
[2] Nucl Med Dept, Diag Clin Quadrantes, Med, Lisbon, Portugal
[3] Univ Lisbon, Human Kinet Fac, CIPER, Lisbon, Portugal
[4] Univ Nova Lisboa, NOVA Med Sch, Lisbon, Portugal
关键词
Heart failure; cardiac innervation; diagnostic and prognostic application; METAIODOBENZYLGUANIDINE UPTAKE; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; NERVOUS ACTIVITY; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DISINTEGRITY; IMPROVEMENT; PARAMETERS; OUTFLOW;
D O I
10.1007/s12350-018-1357-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cardiac autonomic dysfunction as assessed by I-123-metaiodobenzylguanidine (I-123-mIBG) scintigraphy is associated with poor prognosis in heart failure (HF) patients. Although cardiac resynchronization therapy (CRT) has emerged as an effective therapy in improving outcomes on HF patients, its effect on cardiac sympathetic nervous function is still not fully understood. We aimed to study the value of pre-implantation I-123-mIBG late heart-to-mediastinum ratio (HMR) as a predictor of response and outcomes after CRT and to correlate modification in this parameter with CRT response and functional improvement. Methods and Results BETTER-HF (Benefit of exercise training therapy and cardiac resynchronization in HF patients) is a prospective randomized clinical trial including HF patients submitted CRT (mean LVEF 24 +/- 8%, 74% NYHA class >= III) who underwent a clinical, echocardiographic, and scintigraphic assessment before and 6 months after CRT. One-hundred and twenty-one patients were included. Echocardiographic response was observed in 54% and composite outcome of cardiac mortality, cardiac transplant or heart failure hospitalization in 24% of patients. Baseline late HMR was an independent predictor of CRT response (regression coefficient 2.906, 95% CI 0.293-3.903, P .029) and outcomes (HR 0.066 95% CI 0.005-0.880, P .040). At follow-up, I-123-mIBG imaging showed positive changes in cardiac sympathetic nerve activity only in responders to CRT (1.36 +/- 0.14 prior vs. 1.42 +/- 0.16 after CRT, P .039). There was a significant correlation between improvement in late HMR and improvement in peak oxygen consumption (r 0.547, P < .001). Conclusion In our study, baseline cardiac denervation predicted response and clinical outcomes after CRT implantation. Cardiac sympathetic function was improved only in patients who responded to CRT and these positive changes were correlated with improvement in functional capacity.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 50 条
  • [31] Cardiac resynchronization therapy in chronic heart failure: Effect on right ventricular function
    Benz, Dominik C.
    Pazhenkottil, Aju P.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2019, 26 (01) : 133 - 135
  • [32] Cardiac resynchronization therapy in chronic heart failure: Effect on right ventricular function
    Dominik C. Benz
    Aju P. Pazhenkottil
    Journal of Nuclear Cardiology, 2019, 26 : 133 - 135
  • [33] Cardiac resynchronization therapy in heart failure
    Calvert, M
    Freemantle, J
    Cleland, JGF
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) : 305 - 307
  • [34] Cardiac resynchronization therapy for heart failure
    Abraham, WT
    Hayes, DL
    CIRCULATION, 2003, 108 (21) : 2596 - 2603
  • [35] Cardiac resynchronization therapy for heart failure
    Ross H.M.
    Kocovic D.Z.
    Current Treatment Options in Cardiovascular Medicine, 2004, 6 (5) : 365 - 370
  • [36] Cardiac resynchronization therapy for heart failure
    Michael R. Gold
    Current Cardiology Reports, 2006, 8 (5) : 314 - 315
  • [37] Cardiac resynchronization therapy in heart failure
    Koniari, I.
    Apostolakis, E.
    ARCHIVES OF HELLENIC MEDICINE, 2008, 25 (05): : 595 - 601
  • [38] Prognostic implications of mitral regurgitation in heart failure patients undergoing cardiac resynchronization therapy
    Duarte, F. Fabiana
    Coutinho, I.
    Barradas, M. I.
    Oliveira, L.
    Monteiro, A.
    Machado, C.
    Dourado, R.
    Martins, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 15 - 15
  • [39] Clinical and prognostic implications of phenomapping in patients with heart failure receiving cardiac resynchronization therapy
    Riolet, Clemence
    Menet, Aymeric
    Verdun, Stephane
    Altes, Alexandre
    Appert, Ludovic
    Guyomar, Yves
    Delelis, Francois
    Ennezat, Pierre Vladimir
    Guerbaai, Raphaelle A.
    Graux, Pierre
    Tribouilloy, Christophe
    Marechaux, Sylvestre
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2021, 114 (03) : 197 - 210
  • [40] Prognostic value of novel heart failure biomarkers in patients undergoing cardiac resynchronization therapy
    Perge, P.
    Boros, A. M.
    Geller, L.
    Molnar, L.
    Zima, E.
    Forizs, E.
    Merkely, B.
    Szeplaki, G.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1289 - 1289